AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glimecaid-M 1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Medicaid Labs LLP

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimecaid-M 1 Tablet PR

Diabetace-Duo, a dual-action antidiabetic medication, manages type 2 diabetes in adults. This formulation combines two active ingredients to regulate blood glucose. Administer Diabetace-Duo with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can elevate blood sugar, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. This medication complements a comprehensive diabetes management plan, encompassing a balanced diet, physical activity, and weight management as directed by your doctor. Lifestyle modifications are key to effective diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential for prevention. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur in some individuals. Contraindications include type 1 diabetes, diabetic ketoacidosis, and significant kidney or liver impairment. Individuals with a history of cardiovascular disease should inform their physician prior to commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Glimecaid-M 1 Tablet PR

No text provided to rephrase.

Uses of Glimecaid-M 1 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimecaid-M 1 Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Take one Glimecaid-M tablet (PR) with a meal.

Common Side effects of Glimecaid-M 1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimecaid-M 1 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidance. Take one Glimecaid-M tablet (PR) with meals.

How Glimecaid-M 1 Tablet PR works:

Glimecaid-M, a single tablet formulation (PR), unites the antidiabetic actions of glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimecaid-M 1 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimecaid-M 1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated with Glimecaid-M 1 Tablet PR due to potential infant toxicity.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimecaid-M 1 Tablet PR cautiously, potentially requiring dosage modification. Consult your physician. This medication is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimecaid-M 1 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician before use. A low initial dose is typically recommended for individuals with mild to moderate liver disease; the medication is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimecaid-M 1 Tablet PR :

For a missed Glimecaid-M 1 Tablet PR dose, take it immediately if you remember. If your next dose is imminent, omit the forgotten dose and resume your usual dosing schedule. Never take a double dose.

Facts to Know About Glimecaid-M 1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimecaid-M 1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimecaid-M 1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimecaid-M 1 Tablet PR and seek immediate medical attention.
Glimecaid-M 1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Glimepiride-metformin (Glimecaid-M 1 Tablet PR) may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach upset, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimepiride use (Glimecaid-M 1 Tablet PR) can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 is recommended annually by some researchers.
Glimepiride (Glimecaid-M) can lower blood sugar, potentially causing hypoglycemia. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimepiride-Metformin (Glimecaid-M) with alcohol is unsafe. Alcohol can exacerbate Glimecaid-M's effects, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Glimecaid-M 1 Tablet PR
74
MRP 90
17% off